Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells

PLoS ONE - United States
doi 10.1371/journal.pone.0143847
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Molecular Signaling in Multiple Myeloma: Association of RAS/RAF Mutations and MEK/ERK Pathway Activation

Oncogenesis
Cancer ResearchMolecular Biology
2017English

Prohibitins Role in Cellular Survival Through Ras-Raf-Mek-Erk Pathway

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2014English

Targeting the Ras/Raf/Mek/Erk Pathway in Hepatocellular Carcinoma (Review)

Oncology Letters
Cancer ResearchOncology
2017English

Paradoxical Activation of T Cells via Augmented ERK Signaling Mediated by a RAF Inhibitor

Cancer immunology research
Cancer ResearchImmunology
2013English

Modulation of the Akt/Ras/Raf/Mek/Erk Pathway by A3 Adenosine Receptor

Purinergic Signalling
Molecular NeuroscienceCell BiologyMolecular BiologyCellular
2006English

MicroRNA‑98 Suppresses Cell Growth and Invasion of Retinoblastoma via Targeting the IGF1R/k‑Ras/Raf/MEK/ERK Signaling Pathway

International Journal of Oncology
Cancer ResearchOncology
2019English

Oxymatrine Inhibits Proliferation and Migration of Vulvar Squamous Cell Carcinoma Cells via Attenuation of the RAS/RAF/MEK/ERK Pathway

Cancer Management and Research
Oncology
2020English

Epigallocatechin-3-Gallate Inhibits the Growth and Increases the Apoptosis of Human Thyroid Carcinoma Cells Through Suppression of EGFR/RAS/RAF/MEK/ERK Signaling Pathway

Cancer Cell International
Cancer ResearchOncologyGenetics
2019English

Correction: Amphiregulin Enhances Alpha6beta1 Integrin Expression and Cell Motility in Human Chondrosarcoma Cells Through Ras/Raf/Mek/Erk/Ap-1 Pathway

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy